RAG2 and neoplasm: The finding that not even the SCC22b-S, which has only a larger passage number than its parental cell line, failed to induce sustainable tumor growth is particularly surprising, considering the extensive use of the parental cell line in numerous published xenograft studies[39-42], yet in other mouse models than Rag2 KO and not focusing on cetuximab resistance.